32
Participants
Start Date
November 5, 2013
Primary Completion Date
August 31, 2016
Study Completion Date
May 4, 2017
Carfilzomib
Administered by intravenous infusion.
Carboplatin
Administered by intravenous infusion.
Etoposide
Administered by intravenous infusion.
Yale University, Yale Cancer Center, New Haven
UF Health Davis Cancer Pavilion and Shands Med Plaza, Gainesville
Goshen Center for Cancer Care, Goshen
Horizon Oncology Research, Inc., Lafayette
Indiana University Health Ball Memorial Hospital, Muncie
Baptist Health Lexington Clinical Research Center, Lexington
Frederick Memorial Hospital, Frederick
John Theurer Cancer Center at Hackensack UMC, Hackensack
Levine Cancer Institute, Charlotte
Wake Forest Baptist Health, Winston-Salem
The University of Texas MD Anderson Cancer Center, Houston
Juravinski Cancer Centre, Hamilton
"Regional Budgetary Healthcare Institution Kursk Regional Clinical Oncology Dispensary", Kislino
"State budgetary healthcare institution of Arkhangelsk Region Arkhangelsk Clinical Oncological Dispensary", Arkhangelsk
"Federal State Budgetary Scientific Institution N.N. Blokhin Russian Cancer Research Center", Moscow
"State Budgetary Educational Inslitution of Higher Professional Education First St. Petersburg I.P.Pavlov State Medical University", Saint Petersburg
"State Budgetary Healthcare Institution of Yaroslavl Region Regional Clinical Oncological Hospital", Yaroslavl
Lead Sponsor
Amgen
INDUSTRY